The role Time in range depending on the method of assessing glycemic control in diabetes: A review

Despite modern advances in diabetology, diabetes is a progressive non-communicable disease with the possible development of vascular complications, which is a global health problem. Therefore, maintaining optimal glycemic control is important for managing diabetes and preventing the development of a...

Full description

Bibliographic Details
Main Authors: Lyudmila A. Suplotova, Anna S. Sudnitsyna, Tatyana S. Dushina
Format: Article
Language:Russian
Published: ZAO "Consilium Medicum" 2022-06-01
Series:Consilium Medicum
Subjects:
Online Access:https://consilium.orscience.ru/2075-1753/article/viewFile/108922/83036
_version_ 1818256057934282752
author Lyudmila A. Suplotova
Anna S. Sudnitsyna
Tatyana S. Dushina
author_facet Lyudmila A. Suplotova
Anna S. Sudnitsyna
Tatyana S. Dushina
author_sort Lyudmila A. Suplotova
collection DOAJ
description Despite modern advances in diabetology, diabetes is a progressive non-communicable disease with the possible development of vascular complications, which is a global health problem. Therefore, maintaining optimal glycemic control is important for managing diabetes and preventing the development of acute and chronic complications of the disease. One of the parameters for assessing glycemic control is the indicator of time in the target range (Time in range TIR), calculated on the basis of data from continuous glucose monitoring (CGM), which is quite simple and convenient to calculate and use, and also has a proven connection with the development of micro- and macrovascular complications of diabetes. However, the main obstacle to the widespread use of TIR is the limited use of CGM systems. Therefore, of particular interest is the study of the derived indicator of the time in range of glycemia (derived TIR dTIR), obtained on the basis of self-monitoring of blood glucose. In this review, the issues of the relationship of TIR, dTIR with HbA1c levels, the development of micro- and macrovascular complications of diabetes type 1 and 2 are discussed, and the comparability of TIR and dTIR is analyzed.
first_indexed 2024-12-12T17:21:43Z
format Article
id doaj.art-e3124de1b251487e9e0c9049021b8ed0
institution Directory Open Access Journal
issn 2075-1753
2542-2170
language Russian
last_indexed 2024-12-12T17:21:43Z
publishDate 2022-06-01
publisher ZAO "Consilium Medicum"
record_format Article
series Consilium Medicum
spelling doaj.art-e3124de1b251487e9e0c9049021b8ed02022-12-22T00:17:37ZrusZAO "Consilium Medicum"Consilium Medicum2075-17532542-21702022-06-0124424725110.26442/20751753.2022.4.2016744558The role Time in range depending on the method of assessing glycemic control in diabetes: A reviewLyudmila A. Suplotova0https://orcid.org/0000-0001-9253-8075Anna S. Sudnitsyna1https://orcid.org/0000-0002-1932-1686Tatyana S. Dushina2https://orcid.org/0000-0002-6329-593XTyumen State Medical UniversityRegional Clinical Hospital №1Tyumen State Medical UniversityDespite modern advances in diabetology, diabetes is a progressive non-communicable disease with the possible development of vascular complications, which is a global health problem. Therefore, maintaining optimal glycemic control is important for managing diabetes and preventing the development of acute and chronic complications of the disease. One of the parameters for assessing glycemic control is the indicator of time in the target range (Time in range TIR), calculated on the basis of data from continuous glucose monitoring (CGM), which is quite simple and convenient to calculate and use, and also has a proven connection with the development of micro- and macrovascular complications of diabetes. However, the main obstacle to the widespread use of TIR is the limited use of CGM systems. Therefore, of particular interest is the study of the derived indicator of the time in range of glycemia (derived TIR dTIR), obtained on the basis of self-monitoring of blood glucose. In this review, the issues of the relationship of TIR, dTIR with HbA1c levels, the development of micro- and macrovascular complications of diabetes type 1 and 2 are discussed, and the comparability of TIR and dTIR is analyzed.https://consilium.orscience.ru/2075-1753/article/viewFile/108922/83036derived time in rangetime in rangediabetesself-monitoring blood glucosecontinuous glucose monitoring
spellingShingle Lyudmila A. Suplotova
Anna S. Sudnitsyna
Tatyana S. Dushina
The role Time in range depending on the method of assessing glycemic control in diabetes: A review
Consilium Medicum
derived time in range
time in range
diabetes
self-monitoring blood glucose
continuous glucose monitoring
title The role Time in range depending on the method of assessing glycemic control in diabetes: A review
title_full The role Time in range depending on the method of assessing glycemic control in diabetes: A review
title_fullStr The role Time in range depending on the method of assessing glycemic control in diabetes: A review
title_full_unstemmed The role Time in range depending on the method of assessing glycemic control in diabetes: A review
title_short The role Time in range depending on the method of assessing glycemic control in diabetes: A review
title_sort role time in range depending on the method of assessing glycemic control in diabetes a review
topic derived time in range
time in range
diabetes
self-monitoring blood glucose
continuous glucose monitoring
url https://consilium.orscience.ru/2075-1753/article/viewFile/108922/83036
work_keys_str_mv AT lyudmilaasuplotova theroletimeinrangedependingonthemethodofassessingglycemiccontrolindiabetesareview
AT annassudnitsyna theroletimeinrangedependingonthemethodofassessingglycemiccontrolindiabetesareview
AT tatyanasdushina theroletimeinrangedependingonthemethodofassessingglycemiccontrolindiabetesareview
AT lyudmilaasuplotova roletimeinrangedependingonthemethodofassessingglycemiccontrolindiabetesareview
AT annassudnitsyna roletimeinrangedependingonthemethodofassessingglycemiccontrolindiabetesareview
AT tatyanasdushina roletimeinrangedependingonthemethodofassessingglycemiccontrolindiabetesareview